Navigation Links
Longer treatment benefits sleep apnea patients

WHAT: Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. This is the first study to identify the nightly duration of CPAP use needed to gain maximum benefit for daytime alertness and functioning.

Researchers at seven sleep centers in the United States and Canada studied 149 adults with sleep apnea to determine how long they routinely used CPAP each night. In addition, patients were evaluated for daytime symptoms such as excessive daytime sleepiness using two widely accepted assessment tools, and for daytime functioning using a standardized test before treatment and after three months of CPAP therapy. The findings suggest that most patients should use CPAP for at least 7.5 hours each night to realize the greatest possible benefits of therapy.

"Relationship Between Hours of CPAP Use and Achieving Normal Levels of Sleepiness and Daily Functioning," is published in the June issue of the journal SLEEP.

More than 12 million adult Americans are believed to have sleep apnea, a common disorder in which the upper airway is intermittently narrowed during sleep, causing breathing to be difficult or even completely blocked. The CPAP device is worn while the patient sleeps and works by blowing just enough air into the nose to keep the patient's throat open.

Because they often find the CPAP device cumbersome, many patients do not use it consistently or for long enough periods while sleeping. In the current study, for example, patients used CPAP on average about 5 hours a night. The researchers found that although daytime sleepiness could be improved after 4 hours to 6 hours a night, depending on the measurement used, functional status or quality-of-life improvements were maximized after 7.5 hours of use each night. Although individual patient response to CPAP therapy can vary, these latest findings provide a yardstick to help clinicians assess whether a patient's use is optimal.
'"/>

Source:NIH/National Heart, Lung and Blood Institute


Related biology news :

1. Longer-lived rodents have lower levels of thyroid hormone
2. Protein discovery could unlock the secret to better TB treatment
3. Topical treatment shown to inhibit HIV and herpes simplex virus infection
4. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
5. Researchers add new tool to tumor-treatment arsenal
6. Potential treatments for neurofibromatosis
7. Nanoparticles offer new hope for detection and treatment
8. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
9. PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment
10. New understanding of DNA repair may pave way to cancer treatments
11. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):
(Date:6/20/2017)... Pa. , June 20, 2017  Kibow Biotech ... pleased to announce the issuance of a new patent ... or hyperuricemia by the U.S. Patent and Trademark Office ... a winner of the Buzz of Bio award in ... is akin to developing non-drug approaches to chronic disease. ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... of antibody therapeutics from millions-diverse immune repertoires, announces launch of its new ... California. Dave Johnson, PhD, CEO of GigaGen, will present on Surge at the ...
(Date:6/19/2017)... ... June 19, 2017 , ... Tunnell Consulting has been solving ... of the biggest challenges faced by life sciences, biotech and pharmaceuticals companies today is ... Kati Abraham , who is well known in the industry and brings significant ...
(Date:6/16/2017)... Massachusetts (PRWEB) , ... June 16, 2017 , ... ... Data management and analytics solutions, today announced that its Anzo Smart Data Lake® ... and Semantic Technology Solution’ category for the 2017 Software & Information Industry Association ...
Breaking Biology Technology: